You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ER-positive

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial (Letrozole, Atezolizumab)

Withdrawn
  • Breast Cancer
  • (no location specified)
Jun 10, 2022

Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (Palbociclib, trastuzumab, pyrotinib)

Recruiting
  • Estrogen Receptor-positive Breast Cancer
  • HER2-positive Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Hospital
Sep 29, 2021

Metastatic Breast Cancer Trial in Changsha (Pyrotinib Maleate plus Letrozole)

Recruiting
  • Metastatic Breast Cancer
  • Pyrotinib Maleate plus Letrozole
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Oct 12, 2021

ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant

Recruiting
  • ER+ Breast Cancer
  • HER2-negative Breast Cancer
  • Palbociclib 125Mg Tab
  • +5 more
  • Christchurch, United Kingdom
  • +3 more
May 19, 2022

Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)

Not yet recruiting
  • Advanced or Metastatic Breast Cancer
  • AND019 PO QD
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Jul 19, 2022

Breast Cancer, HER2-negative Breast Cancer, Node-negative Breast Cancer Trial in Lexington (Anastrozole 1mg, Letrozole 2.5mg,

Recruiting
  • Breast Cancer
  • +3 more
  • Anastrozole 1mg
  • +3 more
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Jan 3, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Pembrolizumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2023

Breast Tumor, Chemo Effect Trial in Netherlands (trifluridine/tipiracil)

Recruiting
  • Breast Neoplasm
  • Chemotherapy Effect
  • Arnhem, Netherlands
  • +9 more
Mar 3, 2022

HER2-negative Breast Cancer Trial in Georgia, Mexico, United Kingdom (AZD9833)

Recruiting
  • HER2-negative Breast Cancer
  • Batumi, Georgia
  • +18 more
Jan 13, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

ER-Positive, HER2-Negative Breast Cancer Trial in Shanghai (HRS8807, HRS8807?SHR6390)

Recruiting
  • ER-Positive, HER2-Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 15, 2021

Breast Cancer Trial in Shanghai (SCR-6852, Palbociclib)

Recruiting
  • Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 18, 2022

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Alpelisib, Tamoxifen, Infigratinib)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Stanford, California
    Stanford University
Nov 16, 2022

Breast Cancer Trial in United States (Neratinib, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Indianapolis, Indiana
  • +5 more
Mar 2, 2022

Immune Environment in Response to Therapy in Breast Cancer

Recruiting
  • Breast Cancer
  • +3 more
  • Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
  • Philadelphia, Pennsylvania
    Abramson Cancer Center
Sep 15, 2022

Breast Cancer Trial in Sarasota, Nashville (AC699)

Recruiting
  • Breast Cancer
  • Sarasota, Florida
  • +1 more
Jan 3, 2023

Breast Cancer Trial in Guangzhou (Everolimus, Letrozole, Fluorouracil)

Completed
  • Breast Cancer
  • Guangzhou, Guangdong, China
    Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Sep 22, 2021

Breast Cancer Trial in United States (Letrozole, Ribociclib, Placebo)

Active, not recruiting
  • Breast Cancer
  • Little Rock, Arkansas
  • +12 more
Sep 24, 2022

Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)

Completed
  • Metastatic Breast Cancer
  • Chuo-ku, Nihonbashi, Koami-cho, Tokyo, Japan
    Japan Breast Cancer Research Group
Aug 2, 2022

Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

Completed
Has Results
  • Estrogen Receptor Positive Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Triple Negative Breast Cancer, HER2-negative Breast Cancer Trial in Tampa (HER2 - primed Dendritic cells, HER3 - primed

Recruiting
  • Triple Negative Breast Cancer
  • HER2-negative Breast Cancer
  • HER2 - primed Dendritic cells
  • HER3 - primed Dendritic cells
  • Tampa, Florida
    Moffitt Cancer Center
Jan 10, 2023

Metastatic Breast Cancer Trial in Johannesburg (Palbociclib, Exemestane, Goserelin)

Recruiting
  • Metastatic Breast Cancer
  • Johannesburg, South Africa
    Wits Oncology center
Jul 22, 2021

Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer Trial (palbociclib and exemestane plus trastuzumab and

Not yet recruiting
  • Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
  • palbociclib and exemestane plus trastuzumab and pyrotinib
  • (no location specified)
Apr 23, 2021

Metastatic Breast Cancer Trial in United States (Lenvatinib, Pembrolizuma, Fulvestrant)

Not yet recruiting
  • Metastatic Breast Cancer
  • Basking Ridge, New Jersey
  • +6 more
Oct 31, 2023

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023